Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yonas Mehari Tesfamariam"'
Autor:
Kathrin Kuhr, Ina Monsef, Tina Jakob, S. Macherey, Yonas Mehari Tesfamariam, Anne Adams, Axel Heidenreich, Nicole Skoetz
Publikováno v:
Cochrane Database Syst Rev
Background Different bone-modifying agents like bisphosphonates and receptor activator of nuclear factor-kappa B ligand (RANKL)-inhibitors are used as supportive treatment in men with prostate cancer and bone metastases to prevent skeletal-related ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2cf08bebcf600d6e642468642dca316
https://doi.org/10.1002/14651858.cd013020.pub2
https://doi.org/10.1002/14651858.cd013020.pub2
Autor:
Nur Izyan Wan Azelee, Dayang Salyani Abang Mahmod, Yonas Mehari Tesfamariam, Siti Fatimah Zaharah Mohamad Fuzi, Li Yee Chong, Nor Hasmaliana Abdul Manas, Azham Zulkharnain, Hafizah Mahmud
Publikováno v:
Journal of biotechnology. 317
Bacterial pigments are potential substitute of chemical photosensitizer for dye-sensitized solar cell (DSSC) due to its non-toxic property and cost-effective production from microbial fermentation. Serratia nematodiphila YO1 was isolated from waterfa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616428ba5c4bb69078bc551053095d6c
https://pubmed.ncbi.nlm.nih.gov/32348830
https://pubmed.ncbi.nlm.nih.gov/32348830
Autor:
Kathrin Kuhr, A Wöckel, A Weigl, Ina Monsef, Anne Adams, Nicole Skoetz, Tina Jakob, Yonas Mehari Tesfamariam
Publikováno v:
Critical reviews in oncology/hematology. 137
Bone-modifying agents like bisphosphonates and receptor activator of nuclear factor kappaβ ligand (RANK-L) inhibitors are used as supportive treatments in breast cancer patients with bone metastases to prevent skeletal-related events (SREs). Due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07b344359b5e29c0b6aa79fdeee774dc
https://pubmed.ncbi.nlm.nih.gov/31014505
https://pubmed.ncbi.nlm.nih.gov/31014505
Autor:
Axel Heidenreich, Tina Jakob, Yonas Mehari Tesfamariam, S. Macherey, Nicole Skoetz, Kathrin Kuhr, Ina Monsef, Ingrid Becker
Publikováno v:
The Cochrane Library
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of bisphosphonates and RANK‐ligand (RANKL)‐inhibitors for supportive treatment in prostate cancer with bone metastases and to generate a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b68f0c2551f102f59177be451a70225
https://europepmc.org/articles/PMC6494586/
https://europepmc.org/articles/PMC6494586/
Autor:
Yonas Mehari Tesfamariam, Macherey S, Kuhr K, Becker I, Monsef I, Jakob T, Heidenreich A, Skoetz N
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5bcda28dcab83b0cf58f8828843801d7
http://europepmc.org/abstract/PMC/PMC6494586
http://europepmc.org/abstract/PMC/PMC6494586